{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T16:31:54Z","timestamp":1785861114398,"version":"3.56.0"},"reference-count":98,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,9]]},"DOI":"10.1097\/01.cco.0000239884.05914.13","type":"journal-article","created":{"date-parts":[[2006,8,7]],"date-time":"2006-08-07T04:05:54Z","timestamp":1154923554000},"page":"456-462","source":"Crossref","is-referenced-by-count":25,"title":["Signal transduction targets in Kaposi's sarcoma"],"prefix":"10.1097","volume":"18","author":[{"given":"Ryan","family":"Sullivan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce J","family":"Dezube","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry B","family":"Koon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-9-20210128","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.critrevonc.2004.10.009","article-title":"Treatments of AIDS-related Kaposi's sarcoma","volume":"53","author":"Aversa","year":"2005","journal-title":"Crit Rev Oncol Hematol"},{"key":"R2-9-20210128","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.jvoice.2004.04.007","article-title":"Dysphonia due to Kaposi's sarcoma as the presenting symptom of human immunodeficiency virus","volume":"18","author":"Watson","year":"2004","journal-title":"J Voice"},{"key":"R3-9-20210128","doi-asserted-by":"crossref","first-page":"4546","DOI":"10.1073\/pnas.96.8.4546","article-title":"Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma","volume":"96","author":"Dupin","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R4-9-20210128","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1615\/CritRevOncog.v9.i2.20","article-title":"Kaposi's sarcoma pathogenesis: a link between immunology and tumor biology","volume":"9","author":"Ensoli","year":"1998","journal-title":"Crit Rev Oncog"},{"key":"R5-9-20210128","doi-asserted-by":"crossref","first-page":"8218","DOI":"10.1128\/JVI.70.11.8218-8223.1996","article-title":"Kaposi's sarcoma-associated herpesvirus contains G protein-coupled receptor and cyclin D homologs which are expressed in Kaposi's sarcoma and malignant lymphoma","volume":"70","author":"Cesarman","year":"1996","journal-title":"J Virol"},{"key":"R6-9-20210128","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1006\/viro.1996.8386","article-title":"Characterization of a chemokine receptor-related gene in human herpesvirus 8 and its expression in Kaposi's sarcoma","volume":"228","author":"Guo","year":"1997","journal-title":"Virology"},{"key":"R7-9-20210128","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1172\/JCI4461","article-title":"Chemokines activate Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor in mammalian cells in culture","volume":"102","author":"Gershengorn","year":"1998","journal-title":"J Clin Invest"},{"key":"R8-9-20210128","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1006\/bbrc.1998.9557","article-title":"Kaposi's sarcoma-associated herpesvirus (KSHV) chemokine vMIP-II and human SDF-1alpha inhibit signaling by KSHV G protein-coupled receptor","volume":"253","author":"Geras-Raaka","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"key":"R9-9-20210128","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1084\/jem.188.2.405","article-title":"Human interferon-gamma-inducible protein 10 (IP-10) inhibits constitutive signaling of Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor","volume":"188","author":"Geras-Raaka","year":"1998","journal-title":"J Exp Med"},{"key":"R10-9-20210128","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/nrm1529","article-title":"Viral hijacking of G-protein-coupled-receptor signalling networks","volume":"5","author":"Sodhi","year":"2004","journal-title":"Nat Rev Mol Cell Biol"},{"key":"R11-9-20210128","doi-asserted-by":"crossref","first-page":"13571","DOI":"10.1073\/pnas.202476899","article-title":"Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling","volume":"99","author":"Tee","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R12-9-20210128","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1126\/science.7701324","article-title":"Requirement for phosphatidylinositol-3 kinase in the prevention of apoptosis by nerve growth factor","volume":"267","author":"Yao","year":"1995","journal-title":"Science"},{"key":"R13-9-20210128","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S1097-2765(02)00568-3","article-title":"Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase\/akt pathway","volume":"10","author":"Manning","year":"2002","journal-title":"Mol Cell"},{"key":"R14-9-20210128","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S1074-7613(00)80501-4","article-title":"Two signals are necessary for cell proliferation induced by a cytokine receptor gp130: involvement of STAT3 in antiapoptosis","volume":"5","author":"Fukada","year":"1996","journal-title":"Immunity"},{"key":"R15-9-20210128","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.molmed.2005.06.007","article-title":"An expanding role for mTOR in cancer","volume":"11","author":"Guertin","year":"2005","journal-title":"Trends Mol Med"},{"key":"R16-9-20210128","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1101\/gad.1256804","article-title":"Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1\/TSC2 tumor suppressor complex","volume":"18","author":"Brugarolas","year":"2004","journal-title":"Genes Dev"},{"key":"R17-9-20210128","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S1535-6108(03)00187-9","article-title":"TSC2 regulates VEGF through mTOR-dependent and -independent pathways","volume":"4","author":"Brugarolas","year":"2003","journal-title":"Cancer Cell"},{"key":"R18-9-20210128","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0014-5793(00)01181-9","article-title":"ERK activation upon hypoxia: involvement in HIF-1 activation","volume":"468","author":"Minet","year":"2000","journal-title":"FEBS Lett"},{"key":"R19-9-20210128","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1126\/science.1852076","article-title":"Cloning of a factor required for activity of the Ah (dioxin) receptor","volume":"252","author":"Hoffman","year":"1991","journal-title":"Science"},{"key":"R20-9-20210128","doi-asserted-by":"crossref","first-page":"4304","DOI":"10.1073\/pnas.90.9.4304","article-title":"General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia","volume":"90","author":"Wang","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R21-9-20210128","doi-asserted-by":"crossref","first-page":"7987","DOI":"10.1073\/pnas.95.14.7987","article-title":"Regulation of hypoxia-inducible factor 1alpha is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway","volume":"95","author":"Huang","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R22-9-20210128","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1126\/science.1066373","article-title":"A conserved family of prolyl-4-hydroxylases that modify HIF","volume":"294","author":"Bruick","year":"2001","journal-title":"Science"},{"key":"R23-9-20210128","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1126\/science.1059817","article-title":"HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing","volume":"292","author":"Ivan","year":"2001","journal-title":"Science"},{"key":"R24-9-20210128","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1126\/science.1059796","article-title":"Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation","volume":"292","author":"Jaakkola","year":"2001","journal-title":"Science"},{"key":"R25-9-20210128","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/20459","article-title":"The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis","volume":"399","author":"Maxwell","year":"1999","journal-title":"Nature"},{"key":"R26-9-20210128","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/35017054","article-title":"Ubiquitination of hypoxia-inducible factor requires direct binding to the beta-domain of the von Hippel-Lindau protein","volume":"2","author":"Ohh","year":"2000","journal-title":"Nat Cell Biol"},{"key":"R27-9-20210128","doi-asserted-by":"crossref","first-page":"25733","DOI":"10.1074\/jbc.M002740200","article-title":"Hypoxia inducible factor-alpha binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein","volume":"275","author":"Cockman","year":"2000","journal-title":"J Biol Chem"},{"key":"R28-9-20210128","doi-asserted-by":"crossref","first-page":"4298","DOI":"10.1093\/emboj\/19.16.4298","article-title":"Mechanism of regulation of the hypoxia-inducible factor-1 alpha by the von Hippel-Lindau tumor suppressor protein","volume":"19","author":"Tanimoto","year":"2000","journal-title":"Embo J"},{"key":"R29-9-20210128","doi-asserted-by":"crossref","first-page":"10430","DOI":"10.1073\/pnas.190332597","article-title":"Activation of HIF1alpha ubiquitination by a reconstituted von Hippel-Lindau (VHL) tumor suppressor complex","volume":"97","author":"Kamura","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R30-9-20210128","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1007\/s00109-002-0355-1","article-title":"A role for hypoxia and hypoxia-inducible transcription factors in tumor physiology","volume":"80","author":"Acker","year":"2002","journal-title":"J Mol Med"},{"key":"R31-9-20210128","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1023\/A:1023805715476","article-title":"Jak family of kinases in cancer","volume":"22","author":"Verma","year":"2003","journal-title":"Cancer Metastasis Rev"},{"key":"R32-9-20210128","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1038\/sj.onc.1208442","article-title":"KSHV-GPCR and CXCR2 transforming capacity and angiogenic responses are mediated through a JAK2-STAT3-dependent pathway","volume":"24","author":"Burger","year":"2005","journal-title":"Oncogene"},{"key":"R33-9-20210128","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1172\/JCI26322","article-title":"IKK\/NF-kappaB signaling: balancing life and death\u2013a new approach to cancer therapy","volume":"115","author":"Luo","year":"2005","journal-title":"J Clin Invest"},{"key":"R34-9-20210128","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.tibs.2004.11.009","article-title":"Phosphorylation of NF-kappaB and IkappaB proteins: implications in cancer and inflammation","volume":"30","author":"Viatour","year":"2005","journal-title":"Trends Biochem Sci"},{"key":"R35-9-20210128","first-page":"8837","article-title":"Activation of p21-activated kinase 1-nuclear factor kappaB signaling by Kaposi's sarcoma-associated herpes virus G protein-coupled receptor during cellular transformation","volume":"63","author":"Dadke","year":"2003","journal-title":"Cancer Res"},{"key":"R36-9-20210128","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S1359-6101(02)00027-8","article-title":"IL-6 in autoimmune disease and chronic inflammatory proliferative disease","volume":"13","author":"Ishihara","year":"2002","journal-title":"Cytokine Growth Factor Rev"},{"key":"R37-9-20210128","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/1043-4666(90)90069-6","article-title":"Interleukin 6 and expression of its receptor on epidermal keratinocytes","volume":"2","author":"Yoshizaki","year":"1990","journal-title":"Cytokine"},{"key":"R38-9-20210128","doi-asserted-by":"crossref","first-page":"8660","DOI":"10.1128\/JVI.75.18.8660-8673.2001","article-title":"Activation of NF-kappaB by the human herpesvirus 8 chemokine receptor ORF74: evidence for a paracrine model of Kaposi's sarcoma pathogenesis","volume":"75","author":"Pati","year":"2001","journal-title":"J Virol"},{"key":"R39-9-20210128","doi-asserted-by":"crossref","first-page":"505","DOI":"10.4049\/jimmunol.167.1.505","article-title":"Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor constitutively activates NF-kappa B and induces proinflammatory cytokine and chemokine production via a C-terminal signaling determinant","volume":"167","author":"Schwarz","year":"2001","journal-title":"J Immunol"},{"key":"R40-9-20210128","doi-asserted-by":"crossref","first-page":"8252","DOI":"10.1128\/JVI.76.16.8252-8264.2002","article-title":"Transcriptional regulation of the interleukin-6 gene of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus)","volume":"76","author":"Deng","year":"2002","journal-title":"J Virol"},{"key":"R41-9-20210128","doi-asserted-by":"crossref","first-page":"5150","DOI":"10.1038\/sj.onc.1206555","article-title":"The role of Kaposi's sarcoma-associated herpesvirus\/human herpesvirus-8 regulator of transcription activation (RTA) in control of gene expression","volume":"22","author":"West","year":"2003","journal-title":"Oncogene"},{"key":"R42-9-20210128","first-page":"1180","article-title":"Characterization of signaling cascades triggered by human interleukin-6 versus Kaposi's sarcoma-associated herpes virus-encoded viral interleukin 6","volume":"6","author":"Hideshima","year":"2000","journal-title":"Clin Cancer Res"},{"key":"R43-9-20210128","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1182\/blood.V91.6.1858","article-title":"Human herpesvirus type 8 interleukin-6 homologue is functionally active on human myeloma cells","volume":"91","author":"Burger","year":"1998","journal-title":"Blood"},{"key":"R44-9-20210128","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/nm0397-287","article-title":"Kaposi's sarcoma-associated human herpesvirus-8 encodes homologues of macrophage inflammatory protein-1 and interleukin-6","volume":"3","author":"Nicholas","year":"1997","journal-title":"Nat Med"},{"key":"R45-9-20210128","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1128\/JVI.71.1.839-842.1997","article-title":"Human herpesvirus 8 encodes a homolog of interleukin-6","volume":"71","author":"Neipel","year":"1997","journal-title":"J Virol"},{"key":"R46-9-20210128","doi-asserted-by":"crossref","first-page":"4672","DOI":"10.4049\/jimmunol.164.9.4672","article-title":"IL-6 receptor independent stimulation of human gp130 by viral IL-6","volume":"164","author":"Mullberg","year":"2000","journal-title":"J Immunol"},{"key":"R47-9-20210128","doi-asserted-by":"crossref","first-page":"19625","DOI":"10.1074\/jbc.272.31.19625","article-title":"A Kaposi's sarcoma-associated herpesvirus-encoded cytokine homolog (vIL-6) activates signaling through the shared gp130 receptor subunit","volume":"272","author":"Molden","year":"1997","journal-title":"J Biol Chem"},{"key":"R48-9-20210128","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1128\/JVI.75.7.3325-3334.2001","article-title":"Detection of direct binding of human herpesvirus 8-encoded interleukin-6 (vIL-6) to both gp130 and IL-6 receptor (IL-6R) and identification of amino acid residues of vIL-6 important for IL-6R-dependent and -independent signaling","volume":"75","author":"Li","year":"2001","journal-title":"J Virol"},{"key":"R49-9-20210128","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S0198-8859(99)00083-X","article-title":"KSHV-encoded viral IL-6 activates multiple human IL-6 signaling pathways","volume":"60","author":"Osborne","year":"1999","journal-title":"Hum Immunol"},{"key":"R50-9-20210128","doi-asserted-by":"crossref","first-page":"51793","DOI":"10.1074\/jbc.M407382200","article-title":"Kaposi's sarcoma-associated herpesvirus-encoded viral interleukin-6 is secreted and modified differently than human interleukin-6: evidence for a unique autocrine signaling mechanism","volume":"279","author":"Meads","year":"2004","journal-title":"J Biol Chem"},{"key":"R51-9-20210128","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nri748","article-title":"Chemokines: agents for the immunotherapy of cancer?","volume":"2","author":"Homey","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"R52-9-20210128","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1126\/science.274.5293.1739","article-title":"Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV","volume":"274","author":"Moore","year":"1996","journal-title":"Science"},{"key":"R53-9-20210128","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1182\/blood.V95.4.1151.004k37_1151_1157","article-title":"KSHV-encoded CC chemokine vMIP-III is a CCR4 agonist, stimulates angiogenesis, and selectively chemoattracts TH2 cells","volume":"95","author":"Stine","year":"2000","journal-title":"Blood"},{"key":"R54-9-20210128","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1128\/JVI.73.3.2232-2242.1999","article-title":"Kinetics of Kaposi's sarcoma-associated herpesvirus gene expression","volume":"73","author":"Sun","year":"1999","journal-title":"J Virol"},{"key":"R55-9-20210128","doi-asserted-by":"crossref","first-page":"21569","DOI":"10.1074\/jbc.274.31.21569","article-title":"HHV8-encoded vMIP-I selectively engages chemokine receptor CCR8. Agonist and antagonist profiles of viral chemokines","volume":"274","author":"Dairaghi","year":"1999","journal-title":"J Biol Chem"},{"key":"R56-9-20210128","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1126\/science.277.5332.1656","article-title":"A broad-spectrum chemokine antagonist encoded by Kaposi's sarcoma-associated herpesvirus","volume":"277","author":"Kledal","year":"1997","journal-title":"Science"},{"key":"R57-9-20210128","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1126\/science.278.5336.290","article-title":"Angiogenic and HIV-inhibitory functions of KSHV-encoded chemokines","volume":"278","author":"Boshoff","year":"1997","journal-title":"Science"},{"key":"R58-9-20210128","doi-asserted-by":"crossref","first-page":"10933","DOI":"10.1128\/JVI.75.22.10933-10940.2001","article-title":"Human herpesvirus 8 (HHV-8)-encoded cytokines induce expression of and autocrine signaling by vascular endothelial growth factor (VEGF) in HHV-8-infected primary-effusion lymphoma cell lines and mediate VEGF-independent antiapoptotic effects","volume":"75","author":"Liu","year":"2001","journal-title":"J Virol"},{"key":"R59-9-20210128","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/modpathol.3880033","article-title":"Vascular endothelial growth factor receptor-3 (VEGFR-3): a marker of vascular tumors with presumed lymphatic differentiation, including Kaposi's sarcoma, kaposiform and Dabska-type hemangioendotheliomas, and a subset of angiosarcomas","volume":"13","author":"Folpe","year":"2000","journal-title":"Mod Pathol"},{"key":"R60-9-20210128","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0002-9440(10)64344-1","article-title":"Human herpesvirus-8-transformed endothelial cells have functionally activated vascular endothelial growth factor\/vascular endothelial growth factor receptor","volume":"160","author":"Masood","year":"2002","journal-title":"Am J Pathol"},{"key":"R61-9-20210128","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1046\/j.1523-1747.1999.00798.x","article-title":"Vascular endothelial growth factor-C (VEGF-C) and its receptors KDR and flt-4 are expressed in AIDS-associated Kaposi's sarcoma","volume":"113","author":"Skobe","year":"1999","journal-title":"J Invest Dermatol"},{"key":"R62-9-20210128","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1158\/0008-5472.CAN-03-3653","article-title":"The Kaposi's sarcoma-associated herpesvirus (KSHV\/HHV-8)K1 protein induces expression of angiogenic and invasion factors","volume":"64","author":"Wang","year":"2004","journal-title":"Cancer Res"},{"key":"R63-9-20210128","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S1535-6108(03)00024-2","article-title":"Kaposi's sarcoma associated herpesvirus G protein-coupled receptor immortalizes human endothelial cells by activation of the VEGF receptor-2\/KDR","volume":"3","author":"Bais","year":"2003","journal-title":"Cancer Cell"},{"key":"R64-9-20210128","doi-asserted-by":"crossref","first-page":"26216","DOI":"10.1074\/jbc.M411392200","article-title":"Kaposi's sarcoma-associated herpesvirus activation of vascular endothelial growth factor receptor 3 alters endothelial function and enhances infection","volume":"280","author":"Zhang","year":"2005","journal-title":"J Biol Chem"},{"key":"R65-9-20210128","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1096\/fj.03-1466com","article-title":"Biological characterization of angiopoietin-3 and angiopoietin-4","volume":"18","author":"Lee","year":"2004","journal-title":"Faseb J"},{"key":"R66-9-20210128","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0014-5793(99)00008-3","article-title":"Molecular cloning and characterization of a novel angiopoietin family protein, angiopoietin-3","volume":"443","author":"Kim","year":"1999","journal-title":"FEBS Lett"},{"key":"R67-9-20210128","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1126\/science.277.5322.55","article-title":"Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis","volume":"277","author":"Maisonpierre","year":"1997","journal-title":"Science"},{"key":"R68-9-20210128","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/S0092-8674(00)81812-7","article-title":"Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning","volume":"87","author":"Davis","year":"1996","journal-title":"Cell"},{"key":"R69-9-20210128","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/S0092-8674(00)81813-9","article-title":"Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis","volume":"87","author":"Suri","year":"1996","journal-title":"Cell"},{"key":"R70-9-20210128","doi-asserted-by":"crossref","first-page":"15732","DOI":"10.1074\/jbc.274.22.15732","article-title":"Hypoxia and vascular endothelial growth factor selectively up-regulate angiopoietin-2 in bovine microvascular endothelial cells","volume":"274","author":"Oh","year":"1999","journal-title":"J Biol Chem"},{"key":"R71-9-20210128","doi-asserted-by":"crossref","first-page":"11205","DOI":"10.1073\/pnas.172161899","article-title":"Angiopoietin-2 displays VEGF-dependent modulation of capillary structure and endothelial cell survival in vivo","volume":"99","author":"Lobov","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R72-9-20210128","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1016\/S0002-9440(10)65088-2","article-title":"Expression of Tie1, Tie2, and angiopoietins 1, 2, and 4 in Kaposi's sarcoma and cutaneous angiosarcoma","volume":"156","author":"Brown","year":"2000","journal-title":"Am J Pathol"},{"key":"R73-9-20210128","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1158\/0008-5472.972.65.3","article-title":"Targeting tumor angiogenesis with adenovirus-delivered anti-Tie-2 intrabody","volume":"65","author":"Popkov","year":"2005","journal-title":"Cancer Res"},{"key":"R74-9-20210128","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1038\/sj.bjc.6602627","article-title":"Role of insulin-like growth factor 1 receptor signalling in cancer","volume":"92","author":"Larsson","year":"2005","journal-title":"Br J Cancer"},{"key":"R75-9-20210128","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1038\/sj.bjc.6602408","article-title":"Insulin-like growth factor-I receptor activity is essential for Kaposi's sarcoma growth and survival","volume":"92","author":"Catrina","year":"2005","journal-title":"Br J Cancer"},{"key":"R76-9-20210128","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1089\/jmf.2005.8.431","article-title":"Genistein inhibits insulin-like growth factor-I receptor signaling in HT-29 human colon cancer cells: a possible mechanism of the growth inhibitory effect of Genistein","volume":"8","author":"Kim","year":"2005","journal-title":"J Med Food"},{"key":"R77-9-20210128","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1158\/0008-5472.CAN-05-1107","article-title":"In vitro and in vivo antitumor effects of the dual insulin-like growth factor-I\/insulin receptor inhibitor, BMS-554417","volume":"66","author":"Haluska","year":"2006","journal-title":"Cancer Res"},{"key":"R78-9-20210128","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cytogfr.2004.03.005","article-title":"Insight into the physiological functions of PDGF through genetic studies in mice","volume":"15","author":"Betsholtz","year":"2004","journal-title":"Cytokine Growth Factor Rev"},{"key":"R79-9-20210128","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.cytogfr.2004.03.003","article-title":"PDGF signaling in cells and mice","volume":"15","author":"Tallquist","year":"2004","journal-title":"Cytokine Growth Factor Rev"},{"key":"R80-9-20210128","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/S0016-5085(98)70079-4","article-title":"A novel gain-of-function mutation of c-kit gene in gastrointestinal stromal tumors","volume":"115","author":"Nakahara","year":"1998","journal-title":"Gastroenterology"},{"key":"R81-9-20210128","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1126\/science.1079666","article-title":"PDGFRA activating mutations in gastrointestinal stromal tumors","volume":"299","author":"Heinrich","year":"2003","journal-title":"Science"},{"key":"R82-9-20210128","first-page":"4297","article-title":"Effect of c-kit mutation on prognosis of gastrointestinal stromal tumors","volume":"59","author":"Taniguchi","year":"1999","journal-title":"Cancer Res"},{"key":"R83-9-20210128","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1200\/JCO.2005.02.2194","article-title":"Safety, pharmacokinetic, and antitumor activity of SU11248, a novel oral multitarget tyrosine kinase inhibitor, in patients with cancer","volume":"24","author":"Faivre","year":"2006","journal-title":"J Clin Oncol"},{"key":"R84-9-20210128","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1159\/000423635","article-title":"Regulation of PDGF-B and PDGF receptor expression in the pathogenesis of Kaposi's sarcoma in AIDS","volume":"46","author":"Pistritto","year":"1994","journal-title":"Antibiot Chemother"},{"key":"R85-9-20210128","doi-asserted-by":"crossref","first-page":"7046","DOI":"10.1073\/pnas.89.15.7046","article-title":"Expression of platelet-derived growth factor and its receptor in AIDS-related Kaposi sarcoma in vivo suggests paracrine and autocrine mechanisms of tumor maintenance","volume":"89","author":"Sturzl","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R86-9-20210128","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/0014-4827(90)90122-Q","article-title":"Cultured Kaposi's sarcoma-derived cells express functional PDGF A-type and B-type receptors","volume":"187","author":"Werner","year":"1990","journal-title":"Exp Cell Res"},{"key":"R87-9-20210128","first-page":"483","article-title":"Depletion of PDGF from serum inhibits growth of AIDS-related and sporadic Kaposi's sarcoma cells in culture","volume":"4","author":"Roth","year":"1989","journal-title":"Oncogene"},{"key":"R88-9-20210128","doi-asserted-by":"crossref","first-page":"8383","DOI":"10.1128\/JVI.76.16.8383-8399.2002","article-title":"Kaposi's sarcoma-associated herpesvirus-induced upregulation of the c-kit proto-oncogene, as identified by gene expression profiling, is essential for the transformation of endothelial cells","volume":"76","author":"Moses","year":"2002","journal-title":"J Virol"},{"key":"R89-9-20210128","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1200\/JCO.2005.06.079","article-title":"Imatinib-induced regression of AIDS-related Kaposi's sarcoma","volume":"23","author":"Koon","year":"2005","journal-title":"J Clin Oncol"},{"key":"R90-9-20210128","first-page":"251","article-title":"Inhibition of AIDS-Kaposi's sarcoma cell induced endothelial cell invasion by TIMP-2 and a synthetic peptide from the metalloproteinase propeptide: implications for an antiangiogenic therapy","volume":"6","author":"Benelli","year":"1994","journal-title":"Oncol Res"},{"key":"R91-9-20210128","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/00042560-199807010-00002","article-title":"Constitutive release of metalloproteinase-9 (92-kd type IV collagenase) by Kaposi's sarcoma cells","volume":"18","author":"Blankaert","year":"1998","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"R92-9-20210128","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/sj.cgt.7700657","article-title":"AAV-mediated gene transfer of tissue inhibitor of metalloproteinases-1 inhibits vascular tumor growth and angiogenesis in vivo","volume":"11","author":"Zacchigna","year":"2004","journal-title":"Cancer Gene Ther"},{"issue":"16","key":"R93-9-20210128","first-page":"6020","article-title":"Inhibition of Kaposi's sarcoma in vivo by fenretinide","volume":"9","author":"Ferrari","year":"2003","journal-title":"Clin Cancer Res"},{"key":"R94-9-20210128","doi-asserted-by":"crossref","first-page":"4865","DOI":"10.1158\/1078-0432.CCR-03-0672","article-title":"Mechanisms of inhibition of tumor angiogenesis and vascular tumor growth by epigallocatechin-3-gallate","volume":"10","author":"Fassina","year":"2004","journal-title":"Clin Cancer Res"},{"key":"R95-9-20210128","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S1368-7646(03)00060-8","article-title":"HIV protease inhibitors as new treatment options for Kaposi's sarcoma","volume":"6","author":"Barillari","year":"2003","journal-title":"Drug Resist Updat"},{"key":"R96-9-20210128","first-page":"153","article-title":"Matrix metalloproteinase inhibitor COL-3 in the treatment of AIDS-related Kaposi's sarcoma: a phase I AIDS Malignancy Consortium Study","volume":"20","author":"Cianfrocca","year":"2002","journal-title":"J Clin Oncol"},{"key":"R97-9-20210128","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1200\/JCO.2005.04.2614","article-title":"Randomized phase II trial of matrix metalloproteinase inhibitor COL-3 in AIDS-related Kaposi's sarcoma: an AIDS Malignancy Consortium Study","volume":"24","author":"Dezube","year":"2006","journal-title":"J Clin Oncol"},{"key":"R98-9-20210128","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJMoa042831","article-title":"Sirolimus for Kaposi's sarcoma in renal-transplant recipients","volume":"352","author":"Stallone","year":"2005","journal-title":"N Engl J Med"}],"container-title":["Current Opinion in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00124743-200608001-00185","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T15:39:02Z","timestamp":1785857942000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001622-200609000-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9]]},"references-count":98,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006]]}},"URL":"https:\/\/doi.org\/10.1097\/01.cco.0000239884.05914.13","relation":{},"ISSN":["1040-8746"],"issn-type":[{"value":"1040-8746","type":"print"}],"subject":[],"published":{"date-parts":[[2006,9]]}}}